Finland· FI-REL-REL9319

Xefo

A lornoxicam product containing lornoxicam, registered in Finland by Nycomed Oy. The same ATC class is registered in 5 of our 19 countries.

ATC M01AC05

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedXefoATCM01AC05REGISTER NO.FI-REL-REL9319PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Lornoxicam is registered in 5 of 19 countries.

Countries holding a registration under ATC M01AC05 (lornoxicam), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 2 of them publish a price we can compare per daily dose

Lornoxicam · ATC M01AC05

5 / 19 countries

  • Denmark
  • Finlandprice
  • Japan
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lornoxicam costs, country by country.

Normalised to the WHO defined daily dose (12 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Lornoxicam · price per daily dose (12 mg)

USD · FX 28 Sept 2026

  • ES Spain$0.39
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Lornoxicam
Manufacturer
Nycomed Oy
Country
Finland (FI)
ATC code
M01AC05
ATC class
Lornoxicam
Defined daily dose
12 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

82 interactions on record for lornoxicam.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lornoxicam · interactions on record

82 records

82 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Lornoxicam in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lornoxicam products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Xefo, Xefo Rapid
  • Bulgaria · Ксефо Рапид, Лорнадo
  • Denmark · Lornoxicam Takeda, Xefo
  • Spain · Lornoxicam Rapid Meiji
  • Greece · Xefo, Xefo Rapid
  • Hungary · Xefo, Xefo Rapid
  • Lithuania · Xefo
  • Latvia · Xefo
  • Poland · Xefo Rapid
  • Romania · Lornoxicam Rompharm, Xefo Rapid
  • Slovakia · Xefo, Xefo Rapid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c345f6a4-41c5-4e14-b206-25b302b315df
GET /v1/drugs/c345f6a4-41c5-4e14-b206-25b302b315df?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "12",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "mg",
  "strength": "4 mg",
  "atc_label": "lornoksikaami",
  "ma_number": "12737",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL9319",
  "authorised_at": "1997-08-11"
}

See everything about lornoxicam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.